Grow Your Wealth
with Mutual Funds
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 858.9 Cr.
NAV as on 27 jul, 2026
₹ 36.06
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth
Inception Date
10 Jul 2019
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
97.85%
Cash
2.15%
Portfolio Updated on: 09 Jul, 2026
Sector Allocations
Equity
Healthcare
Industrials
Materials
Portfolio Updated on: 27 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.42% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.34% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 13.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.47% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.89% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.60% |
Debt & Credit Risk Analysis
| Alpha | -0.54% |
| Beta | 0.92% |
| Sharpe Ratio | 0.99% |
| Standard Deviation | 16.03% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 13.83% | NA | 6.12% |
| 6 Months | 22.15% | NA | 12.92% |
| 9 Months | 15.65% | NA | 4.47% |
| 1 Year | 13.64% | 13.64% | 6.04% |
| 2 Years | 20.98% | 9.99% | 24.93% |
| 3 Years | 76.24% | 20.79% | 25.71% |
| 5 Years | 89.44% | 13.63% | 19.91% |
| 7 Years | 251.89% | 19.69% | NA |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth is one Equity mutual fund offered by Aditya Birla Sun Life Mutual Fund. Launched on 10 Jul 2019, the fund aims Long term capital growth. investments in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. It manages assets worth ₹858.9 crore as on Tue Mar 31, 2026. The expense ratio stands at 2.3%.
Dhaval Joshi has experience Prior to joining Aditya Birla Sun Life Mutual Fund, he was associated with Sundaram Mutual Fund, Emkay Global Financial Services and Asit C Mehta Investment Intermediates Ltd..
Dhaval Shah has experience Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from Aditya Birla Sun Life Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +5.27% | +14.17% | +22.95% | +15.16% | +22.42% | +15.22% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +5.27% | +14.17% | +22.95% | +15.16% | +22.42% | +15.22% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +5.27% | +14.17% | +22.95% | +15.16% | +22.42% | +15.22% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +5.27% | +14.17% | +22.95% | +15.16% | +22.42% | +15.22% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth | 858.9 | +5.27% | +14.17% | +22.95% | +15.16% | +22.42% | +15.22% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.15 | +24.11% | +17.02% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.47 | +24.11% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹506.05 | +22.55% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹318.78 | +22.55% | +17.02% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹50.72 | +23.36% | +16.17% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹30.55 | +23.36% | +16.17% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 27 Jul 2026 | ₹36.06 |
| 24 Jul 2026 | ₹35.61 |
| 23 Jul 2026 | ₹35.68 |
| 22 Jul 2026 | ₹35.82 |
| 21 Jul 2026 | ₹36.27 |
| 20 Jul 2026 | ₹36.02 |
| 17 Jul 2026 | ₹35.49 |
| 16 Jul 2026 | ₹35.90 |
| 15 Jul 2026 | ₹35.89 |
| 14 Jul 2026 | ₹35.73 |
| 13 Jul 2026 | ₹35.51 |
| 10 Jul 2026 | ₹35.52 |
| 09 Jul 2026 | ₹35.38 |
| 08 Jul 2026 | ₹34.91 |
| 07 Jul 2026 | ₹35.30 |
| 06 Jul 2026 | ₹35.44 |
| 03 Jul 2026 | ₹35.37 |
| 02 Jul 2026 | ₹34.91 |
| 01 Jul 2026 | ₹34.67 |
| 30 Jun 2026 | ₹34.85 |
| 29 Jun 2026 | ₹34.58 |
| 25 Jun 2026 | ₹34.30 |
| 24 Jun 2026 | ₹34.43 |
| 23 Jun 2026 | ₹34.34 |
| 22 Jun 2026 | ₹34.03 |
| 19 Jun 2026 | ₹33.80 |
| 18 Jun 2026 | ₹33.59 |
| 17 Jun 2026 | ₹33.44 |
| 15 Jun 2026 | ₹33.40 |
| 12 Jun 2026 | ₹33.64 |
Portfolio Updated on: 28 Jul, 2026
Fund Growth & Size Analysis
+₹858.9 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth Returns Comparison
Compare Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
Aditya Birla Sun Life ....
No funds found for your search.
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth FAQ'S
- Sharpe Ratio: 0.99%
- Standard Deviation: 16.03%
- Beta: 0.92%
- Alpha: -0.54%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth stand at approximately ₹ 858.9 crore.
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth has delivered the following short-term performance:
- 3 Months Return: 13.83%
- 6 Months Return: 22.15%
The historical growth of the Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth is reflected through its CAGR returns:
- 3 Year CAGR: 20.79%
- 5 Year CAGR: 13.63%
- Return Since Launch: 19.95%
The portfolio of Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth is distributed across different asset classes as follows:
- Equity: 97.85%
- Other Assets: 2.15%
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth is managed by Dhaval Shah, representing Aditya Birla Sun Life Mutual Fund.
The Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.42% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.34% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 13.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.47% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.89% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.60% of the portfolio
Major sector exposures in Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth are:
- Healthcare – accounts for 1,051.29% of the portfolio
- Industrials – accounts for 17.39% of the portfolio
- Materials – accounts for 11.86% of the portfolio
